Home » Topics » BioWorld Science

BioWorld Science
RSS

KBP Biosciences patents new bacterial LpxC inhibitors

Sep. 3, 2019

UCn2 gene transfer improves diabetes-related left-ventricular dysfunction in mice

Sep. 3, 2019

Eicosis' soluble epoxide hydrolase inhibitor EC-5026 to enter the clinic

Sep. 3, 2019

Lower affinity means lower affinity, but higher persistence, for CAR T cells

Sep. 3, 2019

Alcohol consumption is deceased with FGFR1 inhibition in rodents

Sep. 3, 2019

First preclinical data presented on miR-132 inhibitor CDR132L in heart failure model

Sep. 3, 2019

Panitumumab-IRDye800 in phase II for metastatic lymph node identification in HNSCC

Sep. 3, 2019

POU3F3 disruptions linked to neurodevelopmental disorder

Sep. 3, 2019

Checkpoint blockade protects from homeostatic inhibition and amplifies antitumor T-cell responses

Sep. 3, 2019

Preclinical characterization of the novel covalent Inhibitor of CDK7, SY-1365

Sep. 3, 2019

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...